Core Viewpoint - The National Medical Products Administration has introduced ten measures to support the innovation and development of high-end medical devices, including medical robots, advanced medical imaging equipment, and AI medical devices, which is expected to benefit companies like Kangguan Technology [1][2]. Company Overview - Kangguan Medical, a subsidiary of Shenzhen Kangguan Technology Co., Ltd., was established in 2015 and is recognized as a national high-tech enterprise [1]. - The company’s medical display products cover a full range of medical imaging products, including radiology diagnostic monitors and endoscopic monitors, playing a crucial role in surgical visualization, consultation collaboration, and intelligent radiology diagnosis [1]. Product Innovations - The endoscopic monitor utilizes self-developed RGB color calibration technology, complies with DICOM international standards, and supports high-precision 3D imaging, enhancing surgical efficiency and safety during procedures like "Da Vinci" robotic surgeries [1]. - The AI-integrated medical imaging machine features dynamic lesion recognition and model training capabilities, optimizing hospital radiology workflows and reducing reliance on high-level physicians [2]. Market Expansion - Kangguan Medical's display products are currently installed in over 1,000 hospitals across more than 30 provinces in China [2]. - The company aims to leverage its parent company's technological strength to iterate on medical display hardware and integrate AI-assisted diagnostic algorithms, creating a comprehensive color management and intelligent terminal display solution [2].